Login
$CSBR
$4.83 -$0.03 (0.62%) Close

Insider Transactions

What Champions Oncology Inc's executives and directors are doing with their own shares, from SEC Form 3/4/5 filings — separating what the filings state (awards, withholding, disclosed plans) from what only the pattern of dates shows.

Insider trades

3 months 12 months
Open-market buys 0 0
Sells 0 0
Total trades 1 2

Shares traded

3 months 12 months
Acquired 69,794 164,199
Disposed 0 0
Net activity +69,794 +164,199

See the story behind these numbers

View rich charts and dive into the patterns of specific insiders — who is accumulating, who is winding down, and which sale explanations the filings actually support.

Open-market buyer Disclosed 10b5-1 Heavy discretionary Sign up free

All transactions

Insider Relation Date Transaction Shares Price Value Shares held
Ackerman Joel Director Oct 15 Exercise / conversion · M +69,794 $1.60 +$112K 1,126,333
Ackerman Joel Director Oct 30 Exercise / conversion · M +94,405 $2.10 +$198K 1,056,539
Breitfeld Philip P. Director Mar 25 Other Transaction · J −4,150 — — 5,717
Ackerman Joel Director Oct 31 Exercise / conversion · M +16,667 $5.43 +$90.5K 962,134
Ackerman Joel Director Oct 31 Exercise / conversion · M +88,470 $2.10 +$186K 945,467
Mendelson Daniel Newman Director Jan 12 Open-market buy · P +1,000 $6.50 +$6.5K 198,625
Mendelson Daniel Newman Director Jan 11 Open-market buy · P +2,000 $6.27 +$12.5K 197,625
Mendelson Daniel Newman Director Jan 10 Open-market buy · P +2,944 $6.31 +$18.6K 195,625
Mendelson Daniel Newman Director Jan 09 Open-market buy · P +3,000 $6.25 +$18.8K 192,681
Mendelson Daniel Newman Director Jan 08 Open-market buy · P +1,000 $6.15 +$6.15K 189,681
Mendelson Daniel Newman Director Jan 05 Open-market buy · P +2,000 $6.09 +$12.2K 188,681
Mendelson Daniel Newman Director Jan 04 Open-market buy · P +3,000 $6.12 +$18.4K 186,681
Mendelson Daniel Newman Director Jan 03 Open-market buy · P +500 $5.83 +$2.92K 183,681
Mendelson Daniel Newman Director Dec 21 Open-market buy · P +2,500 $4.92 +$12.3K 183,181
Mendelson Daniel Newman Director Dec 20 Open-market buy · P +2,100 $4.82 +$10.1K 180,681
Mendelson Daniel Newman Director Dec 19 Open-market buy · P +5,000 $4.75 +$23.8K 178,581
Ackerman Joel Director Oct 17 Exercise / conversion · M +114,552 $2.10 +$241K 856,997
Mendelson Daniel Newman Director Oct 11 Open-market buy · P +5,000 $6.40 +$32K 163,081
Mendelson Daniel Newman Director Oct 10 Open-market buy · P +1,100 $6.41 +$7.05K 158,081
Mendelson Daniel Newman Director Oct 06 Open-market buy · P +1,530 $6.48 +$9.91K 156,981

Create Account

Sign up for free to unlock this feature.

Already have an account? Sign in

Premium Feature

This feature requires a premium subscription to unlock unlimited historical data and advanced analysis tools.

Premium includes:

  • Unlimited historical financial data
  • Advanced analytics and insights
  • Priority support